Nuveen Asset Management, LLC - ATARA BIOTHERAPEUTICS INC ownership

ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 119 filers reported holding ATARA BIOTHERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of ATARA BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$196,640
+91.7%
132,865
+108.5%
0.00%
Q2 2023$102,589
+2028.4%
63,720
-96.2%
0.00%
-100.0%
Q1 2023$4,820
+15.3%
1,662,112
+30.4%
0.00%0.0%
Q4 2022$4,182
-99.8%
1,274,847
+144.0%
0.00%
+100.0%
Q3 2022$1,975,000
-51.4%
522,502
+0.2%
0.00%
-50.0%
Q2 2022$4,062,000
-59.5%
521,426
-51.0%
0.00%
-33.3%
Q1 2022$10,023,000
-45.2%
1,065,170
-8.2%
0.00%
-40.0%
Q4 2021$18,289,000
-3.7%
1,160,460
+9.4%
0.01%
-16.7%
Q3 2021$18,987,000
+6.4%
1,060,739
-7.6%
0.01%
+20.0%
Q2 2021$17,847,000
+10.8%
1,147,707
+2.4%
0.01%0.0%
Q1 2021$16,102,000
-20.8%
1,121,297
+8.3%
0.01%
-28.6%
Q4 2020$20,324,000
+99.3%
1,035,356
+31.6%
0.01%
+75.0%
Q3 2020$10,196,000
+70.2%
786,735
+91.3%
0.00%
+100.0%
Q2 2020$5,992,000
+73.6%
411,267
+1.4%
0.00%0.0%
Q1 2020$3,451,000
-28.4%
405,544
+38.6%
0.00%0.0%
Q4 2019$4,819,000
+51.7%
292,570
+30.0%
0.00%
+100.0%
Q3 2019$3,177,000
-20.7%
225,035
+13.0%
0.00%
-50.0%
Q2 2019$4,006,000199,1950.00%
Other shareholders
ATARA BIOTHERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Redmile Group, LLC 2,275,765$43,308,0004.43%
RTW INVESTMENTS, LP 473,126$9,004,0003.27%
Baupost Group 5,359,632$101,994,0001.47%
12 West Capital Management LP 398,700$7,587,0001.05%
BRIDGER MANAGEMENT, LLC 739,444$14,072,0000.97%
Cormorant Asset Management, LP 150,000$2,855,0000.43%
ArrowMark Colorado Holdings LLC 850,040$16,176,0000.36%
Virtus ETF Advisers LLC 11,431$218,0000.30%
Visium Asset Management, LP 606,221$11,536,0000.20%
EAGLE ASSET MANAGEMENT INC 1,025,988$19,524,0000.14%
View complete list of ATARA BIOTHERAPEUTICS INC shareholders